2.54(1.02%) Volume: 59,050 10:29AM EST| Market Cap : 21.61 B | Enterprise Value : 22.52 B | P/E (TTM) : 52.26 | P/B : 106.89 |
|---|
NAS:IDXX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IDXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
IDEXX Laboratories's Earnings per Share (Diluted) for the three months ended in Sep. 2019 was USD 1.24. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was USD 4.82.
IDEXX Laboratories's EPS (Basic) for the three months ended in Sep. 2019 was USD 1.26. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2019 was USD 4.90.
IDEXX Laboratories's EPS without NRI for the three months ended in Sep. 2019 was USD 1.24. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2019 was USD 4.82.
During the past 12 months, IDEXX Laboratories's average EPS without NRIGrowth Rate was 29.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 27.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 14.60% per year.
During the past 13 years, IDEXX Laboratories's highest 3-Year average EPS without NRI Growth Rate was 50.20% per year. The lowest was 0.00% per year. And the median was 15.90% per year.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
| IDEXX Laboratories Quarterly Data | ||||||||||||||||||||
| Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | |
| Earnings per Share (Diluted) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.05 | 0.98 | 1.17 | 1.43 | 1.24 |
* The bar in red indicates where IDEXX Laboratories's Earnings per Share (Diluted) falls into.
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
IDEXX Laboratories's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2018 is calculated as
| Diluted Earnings Per Share (A: Dec. 2018 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Diluted Average) |
| = | (377.031 | - | 0) | / | 88.470 | |
| = | 4.26 |
IDEXX Laboratories's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2019 is calculated as
| Diluted Earnings Per Share (Q: Sep. 2019 ) | = | (Net Income | - | Preferred Dividends | / | Shares Outstanding (Diluted Average) |
| = | (108.837 | - | 0) | / | 87.667 | |
| = | 1.24 |
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was 0.98 (Dec. 2018 ) + 1.17 (Mar. 2019 ) + 1.43 (Jun. 2019 ) + 1.24 (Sep. 2019 ) = USD 4.82
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
No Headline
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP